02 Oct 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Japan's Daiichi Sankyo has decided to reorganize three of its Japanese supply chain subsidiaries, Daiichi Sankyo Propharma (DSPP), Daiichi Sankyo Chemical Pharma (DSCP) and Daiichi Sankyo Logistics (DSLG) into two companies by April 2015.
The reorganization will be done by April 2015 and is expected to build a competitive production system on a global scale. Based on the decision, the current DSPP and DSCP Odawara plants will be integrated into one plant as of April 2013.
With regard to its domestic supply chain subsidiaries, Daiichi Sankyo currently utilizes DSPP for production of API and dosage forms, DSCP for production of API and intermediates, and DSLG for logistics. Through the reorganization of these three companies into two companies responsible for API production and dosage form/logistics by April 2015, each function will be enhanced and made structurally competitive on a global level.